Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This protocol describes a straightforward and minimally invasive method for transplanting and imaging NIT-1 cells in non-obese diabetic (NOD)-severe combined immunodeficient mice challenged with splenocytes purified from spontaneously diabetic NOD mice.

Abstract

Type 1 diabetes is characterized by the autoimmune destruction of the insulin-producing beta cells of the pancreas. A promising treatment for this disease is the transplantation of stem cell-derived beta cells. Genetic modifications, however, may be necessary to protect the transplanted cells from persistent autoimmunity. Diabetic mouse models are a useful tool for the preliminary evaluation of strategies to protect transplanted cells from autoimmune attack. Described here is a minimally invasive method for transplanting and imaging cell grafts in an adoptive transfer model of diabetes in mice. In this protocol, cells from the murine pancreatic beta cell line NIT-1 expressing the firefly luciferase transgene luc2 are transplanted subcutaneously into immunodeficient non-obese diabetic (NOD)-severe combined immunodeficient (scid) mice. These mice are simultaneously injected intravenously with splenocytes from spontaneously diabetic NOD mice to transfer autoimmunity. The grafts are imaged at regular intervals via non-invasive bioluminescent imaging to monitor the cell survival. The survival of mutant cells is compared to that of control cells transplanted into the same mouse.

Introduction

Type 1 diabetes (T1D) is caused by the autoimmune destruction of the insulin-producing beta cells of the pancreas. The loss of beta cell mass results in insulin deficiency and hyperglycemia. T1D patients rely on multiple daily injections of exogenous insulin and experience episodes of severe hyperglycemia and hypoglycemia throughout their lives. The complications related to these episodes include diabetic retinopathy, decreased kidney function, and neuropathy1.

Insulin injections are a treatment but not a cure for T1D. Replacing the lost beta cell mass, however, has the potential to reverse the disease by enabling pa....

Protocol

figure-protocol-68
Figure 1: The workflow for transplanting and imaging grafts in an adoptive transfer model of diabetes in mice. NIT-1 cells expressing the firefly transgene luciferase (luc2) are transplanted subcutaneously into NOD-scid mice. The mice are simultaneously injected with autoreactive splenocytes isolated from a spontaneously diabetic NOD m.......

Representative Results

An overview of the protocol is outlined in Figure 1. The survival of two cell lines, such as a mutant and a non-targeting control, may be compared, or the survival of one cell line may be measured in multiple groups of mice, such as drug-treated mice versus vehicle-treated controls. Figure 3A shows three 8-week-old female NOD-scid mice transplanted with a non-targeting control (left) and a mutant (right) cell line. The mice were also injected intravenously with .......

Discussion

T1D is a devastating disease for which no cure currently exists. Beta cell replacement therapy offers a promising treatment for patients with this disease, but the critical barrier to this strategy is the potential for recurrent autoimmune attack against the transplanted beta cells. The genetic engineering of SC-beta cells to reduce their immune visibility or susceptibility is one potential solution to this problem. Described here is a protocol for non-invasively imaging transplanted beta cells to measure their survival .......

Acknowledgements

We thank Dr. Erica P. Cai and Dr. Yuki Ishikawa for developing the method described in this protocol (see ref. 11). Research in S.K. and P.Y.'s laboratories is supported by grants from the National Institutes of Health (NIH) (R01DK120445, P30DK036836), JDRF, the Harvard Stem Cell Institute, and the Beatson Foundation. T.S. was supported by a postdoctoral fellowship from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (T32 DK007260-45), and K.B. was supported in part by a fellowship from the Mary K. Iacocca Foundation.

....

Materials

NameCompanyCatalog NumberComments
0.05% Trypsin, 0.53 mM EDTACorning25-052-CI
293FTInvitrogenR70007Fast-growing, highly transfectable clonal isolate derived from human embryonal kidney cells transformed with the SV40 large T antigen
ACK Lysing BufferGibcoA10492-01
Alcohol prep pads, 70% Isopropyl alcoholAmazon/Ever Ready First AidB08NWF31DX
BD 5ml Syringe Luer-Lok TipBD309646
BD PrecisionGlide Needle 26G x 5/8 (0.45 mm x 16 mm) Sub-QBD305115
BD 1 mL TB Syringe Slip TipBD309659
Blasticidin S HClCorning 30-100-RB
Cell strainer premium SureStrain, 70 µm, sterileSouthern LabwareC4070Or use similar sterile strainer with 40-70um pore size
CellDrop automated cell counterDenovixCellDrop BF-PAYGOr use similar cell counter device
Corning 100 mL Penicillin-Streptomycin Solution, 100xCorning30-002-CI
Disposable Aspirating Pipets, Polystyrene, Sterile, Capacity=2 mLVWR414004-265Or use similar aspirating pipette
D-Luciferin, Potassium Salt , Molecular Biology Grade, Powder, >99%GoldbioLUCK-100
DMEM, high glucose, pyruvate, no glutamineGibco10313039
Falcon BD tubes, 50 mLFisher Scientific14-959-49A
Fetal Bovine SerumGibco10437-028
Forceps premium for tissues, 1 x 2 teeth 5 in, German SteelFisher Scientific13-820-074
Glucose urine test stripCalifornia Pet Pharmacyu-tsg100Or use similar test strip for glucose measurments in urine/blood
GlutaMAX–1 (100x)Gibco35050-061
Infrared heating lampCole Parmer03057-00Or use similar infrared lamp 
Insulin syringe 0.5 mL, U-100 29 G 0.5 inBecton Dickinson309306
Isoflurane, USPPiramal Critical Care6679401725
IVIS Spectrum in vivo imaging systemPerkin Elmer124262Instrument for non-invasively collecting bioluminescent images of transplanted cells
Living Image Analysis SoftwarePerkin Elmer128113Software for collecting and quantifying bioluminescent signal
Microcentrifuge tubes seal-rite, 1.5 mLUSA Scientific1615-5510Or use similar sterile microcentrifuge tubes
NIT-1ATCCCRL-2055Pancreatic beta-celll line derived from NOD/Lt mice
NOD.Cg-Prkdcscid/JThe Jackson Laboratory001303Mice homozygous for the severe combined immune deficiency spontaneous mutation Prkdcscid, commonly referred to as scid, are characterized by an absence of functional T cells and B cells, lymphopenia, hypogammaglobulinemia, and a normal hematopoietic microenvironment.
NOD/ShiLtJThe Jackson Laboratory001976The NOD/ShiLtJ strain of mice (commonly called NOD) is a polygenic model for autoimmune type 1 diabetes
PBS, pH 7.4Thermo Fisher Scientific10010031No calcium, no magnesium, no phenol red
pCMV-VSV-GAddgene8454
pLenti-luciferase-blastMade in-housePlasmid available upon requestSee Supplemental File 1
pMD2.GAddgene12259
pMDLg/pRREAddgene12251
Polyethylenimine, Linear, MW 25,000, Transfection Grade (PEI 25K)Fisher ScientificNC1014320
pRSV-RevAddgene12253
Restrainer for rodents, broome-style round 1 inFisher Scientific01-288-32A
Scissors, sharp-pointedFisher Scientific08-940Or use other scissors made of surgical-grade stainless steel
Tissue-culture treated culture dishesMillipore SigmaCLS430167-20EAOr use other sterile cell culture-treated Petri dishes
Tweezers/Forceps, fine precision medium tippedFisher Scientific12-000-157

References

  1. Katsarou, A., et al. Type 1 diabetes mellitus. Nature Reviews Disease Primers. 3, 17016 (2017).
  2. Shapiro, A. M., Pokrywczynska, M., Ricordi, C. Clinical pancreatic islet transplantation. Nature Reviews Endocrinology. 13 (5), 268-277 (2017).....

Explore More Articles

Bioluminescent MonitoringGraft SurvivalAdoptive TransferAutoimmune DiabetesMiceCell CultureTransplantImagingTail Vein InjectionIsofluraneSubcutaneous InjectionCell Suspension

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved